Medtronic's Clinical Trial Begins for Spine Neurostimulator Device
The study is a prospective randomized test of the Multicolumn Implantable Lead Stimulation for Predominant Low Back Pain, according to the report. It will look at 300 individuals with chronic low back pain at 30 centers worldwide.
The Medtronic neurostimulation therapy delivers mild electrical pulses to the spinal cord to block pain signals from reaching the brain.
More Articles on Spine:
How to Develop a Successful Spine Center of Excellence
10 Spine Surgeons & Specialists on the Move
Job Opening at New York Medical Group for Clinical Documentation Specialist
© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.